Intracellular delivery of the p38 mitogen-activated protein kinase Inhibitor SB202190 [4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole] in renal tubular Cells: a novel strategy to treat renal fibrosis

J. Prakash; M. Sandovici; V. Saluja; M. Lacombe; R.Q.J. Schaapveld; M.H. de Borst; H. van Goor; R.H. Henning; J.H. Proost; F. Moolenaar; G. Keri; D.F.K. Meijer; K. Poelstra; R.J. Kok

Intracellular delivery of the p38 mitogen-activated protein kinase Inhibitor SB202190 [4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole] in renal tubular Cells: a novel strategy to treat renal fibrosis

J. Prakash
, M. Sandovici
, V. Saluja
, M. Lacombe
, R.Q.J. Schaapveld
, M.H. de Borst
, H. van Goor
, R.H. Henning
, J.H. Proost
, F. Moolenaar
, G. Keri
, D.F.K. Meijer
, K. Poelstra
, R.J. Kok

Dept of Pharmaceutical Sciences

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1-12
Number of pages	12
Journal	Journal of Pharmacology and Experimental Therapeutics
Volume	319
Publication status	Published - 2006

Keywords

Medical technology
Farmacie(FARM)
Biomedische technologie en medicijnen
Pharmacology

Access to Document

2006 38
Open Access (free)
Final published version, 909 KB

Cite this

Prakash, J., Sandovici, M., Saluja, V., Lacombe, M., Schaapveld, R. Q. J., de Borst, M. H., van Goor, H., Henning, R. H., Proost, J. H., Moolenaar, F., Keri, G., Meijer, D. F. K., Poelstra, K., & Kok, R. J. (2006). Intracellular delivery of the p38 mitogen-activated protein kinase Inhibitor SB202190 [4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole] in renal tubular Cells: a novel strategy to treat renal fibrosis. Journal of Pharmacology and Experimental Therapeutics, 319, 1-12.

@article{3205b2d44e7946c4af2976312ddbdf90,

title = "Intracellular delivery of the p38 mitogen-activated protein kinase Inhibitor SB202190 [4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole] in renal tubular Cells: a novel strategy to treat renal fibrosis",

keywords = "Medical technology, Farmacie(FARM), Biomedische technologie en medicijnen, Pharmacology",

author = "J. Prakash and M. Sandovici and V. Saluja and M. Lacombe and R.Q.J. Schaapveld and \{de Borst\}, M.H. and \{van Goor\}, H. and R.H. Henning and J.H. Proost and F. Moolenaar and G. Keri and D.F.K. Meijer and K. Poelstra and R.J. Kok",

year = "2006",

language = "Undefined/Unknown",

volume = "319",

pages = "1--12",

journal = "Journal of Pharmacology and Experimental Therapeutics",

issn = "0022-3565",

publisher = "Elsevier Inc.",

}

Prakash, J, Sandovici, M, Saluja, V, Lacombe, M, Schaapveld, RQJ, de Borst, MH, van Goor, H, Henning, RH, Proost, JH, Moolenaar, F, Keri, G, Meijer, DFK, Poelstra, K & Kok, RJ 2006, 'Intracellular delivery of the p38 mitogen-activated protein kinase Inhibitor SB202190 [4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole] in renal tubular Cells: a novel strategy to treat renal fibrosis', Journal of Pharmacology and Experimental Therapeutics, vol. 319, pp. 1-12.

Intracellular delivery of the p38 mitogen-activated protein kinase Inhibitor SB202190 [4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole] in renal tubular Cells: a novel strategy to treat renal fibrosis. / Prakash, J.; Sandovici, M.; Saluja, V. et al.
In: Journal of Pharmacology and Experimental Therapeutics, Vol. 319, 2006, p. 1-12.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Intracellular delivery of the p38 mitogen-activated protein kinase Inhibitor SB202190 [4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole] in renal tubular Cells: a novel strategy to treat renal fibrosis

AU - Prakash, J.

AU - Sandovici, M.

AU - Saluja, V.

AU - Lacombe, M.

AU - Schaapveld, R.Q.J.

AU - de Borst, M.H.

AU - van Goor, H.

AU - Henning, R.H.

AU - Proost, J.H.

AU - Moolenaar, F.

AU - Keri, G.

AU - Meijer, D.F.K.

AU - Poelstra, K.

AU - Kok, R.J.

PY - 2006

Y1 - 2006

KW - Medical technology

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Pharmacology

M3 - Article

SN - 0022-3565

VL - 319

SP - 1

EP - 12

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

ER -